instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
BACKGROUND
Oligo-articular juvenile idiopathic arthritis (Oligo JIA) is the most common subtype of juvenile idiopathic arthritis. Intra-articular corticosteroid (IAC) injec... | TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33743721 | 19,731,679 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin atrophy'. | Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
BACKGROUND
Oligo-articular juvenile idiopathic arthritis (Oligo JIA) is the most common subtype of juvenile idiopathic arthritis. Intra-articular corticosteroid (IAC) injec... | TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33743721 | 19,731,679 | 2021-03-20 |
What was the administration route of drug 'TRIAMCINOLONE ACETONIDE'? | Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
BACKGROUND
Oligo-articular juvenile idiopathic arthritis (Oligo JIA) is the most common subtype of juvenile idiopathic arthritis. Intra-articular corticosteroid (IAC) injec... | Intra-articular | DrugAdministrationRoute | CC BY | 33743721 | 19,731,679 | 2021-03-20 |
What was the dosage of drug 'TRIAMCINOLONE ACETONIDE'? | Response to treatment with intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligo articular juvenile idiopathic arthritis.
BACKGROUND
Oligo-articular juvenile idiopathic arthritis (Oligo JIA) is the most common subtype of juvenile idiopathic arthritis. Intra-articular corticosteroid (IAC) injec... | 1.2?1.7 MG/KG | DrugDosageText | CC BY | 33743721 | 19,731,679 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute pulmonary oedema'. | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | BETAMETHASONE, MAGNESIUM SULFATE, NIFEDIPINE, RITODRINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743806 | 19,120,814 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | BETAMETHASONE, MAGNESIUM SULFATE, NIFEDIPINE, RITODRINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743806 | 19,120,814 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fluid overload'. | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | BETAMETHASONE, MAGNESIUM SULFATE, NIFEDIPINE, RITODRINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743806 | 19,288,146 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | BETAMETHASONE, MAGNESIUM SULFATE, NIFEDIPINE, RITODRINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743806 | 19,120,814 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Premature labour'. | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | BETAMETHASONE DIPROPIONATE, MAGNESIUM SULFATE, NIFEDIPINE, RITODRINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33743806 | 19,101,845 | 2021-03-21 |
What was the administration route of drug 'MAGNESIUM SULFATE'? | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33743806 | 19,120,814 | 2021-03-21 |
What was the administration route of drug 'NIFEDIPINE'? | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | Oral | DrugAdministrationRoute | CC BY | 33743806 | 19,120,814 | 2021-03-21 |
What was the administration route of drug 'RITODRINE HYDROCHLORIDE'? | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33743806 | 19,120,814 | 2021-03-21 |
What was the outcome of reaction 'Exposure during pregnancy'? | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | Recovered | ReactionOutcome | CC BY | 33743806 | 19,123,786 | 2021-03-21 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | Recovered | ReactionOutcome | CC BY | 33743806 | 19,101,845 | 2021-03-21 |
What was the outcome of reaction 'Premature labour'? | Noninvasive positive-pressure ventilation in pregnancy to treat acute pulmonary edema induced by tocolytic agents: a case report.
BACKGROUND
We report a case of pulmonary edema induced by tocolytic agents that was successfully managed with noninvasive positive-pressure ventilation (NPPV) and resulted in extended gestat... | Recovered | ReactionOutcome | CC BY | 33743806 | 19,101,845 | 2021-03-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular pseudoaneurysm'. | Late massive radial artery pseudoaneurysm following cardiac catheterization: A case report.
BACKGROUND
Transradial artery approach for cardiac catheterization was first introduced in the late 1980s and has now become the approach of choice due to its anatomical advantage, reduction in complications, and overall improve... | AMLODIPINE BESYLATE, APIXABAN, ISOSORBIDE DINITRATE, METOPROLOL | DrugsGivenReaction | CC BY | 33744797 | 19,205,865 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute promyelocytic leukaemia'. | A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide.
In metastatic castration-resistant prostate cancer (mCRPC), assessing tre... | ENZALUTAMIDE | DrugsGivenReaction | CC BY-NC-ND | 33744812 | 19,072,367 | 2021-04 |
What was the administration route of drug 'ENZALUTAMIDE'? | A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide.
In metastatic castration-resistant prostate cancer (mCRPC), assessing tre... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33744812 | 19,072,367 | 2021-04 |
What was the dosage of drug 'ENZALUTAMIDE'? | A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide.
In metastatic castration-resistant prostate cancer (mCRPC), assessing tre... | 160 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33744812 | 19,072,367 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal carcinoma'. | Three resected cases of esophageal carcinoma considered as being secondary solid tumors after bone marrow transplantation.
BACKGROUND
Bone marrow transplantation is now an established treatment for some hematopoietic disorders and hematopoietic malignancies, and secondary solid tumors that develop after bone marrow tra... | METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY | 33744998 | 19,089,457 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia aspiration'. | Three resected cases of esophageal carcinoma considered as being secondary solid tumors after bone marrow transplantation.
BACKGROUND
Bone marrow transplantation is now an established treatment for some hematopoietic disorders and hematopoietic malignancies, and secondary solid tumors that develop after bone marrow tra... | METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY | 33744998 | 19,089,457 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Three resected cases of esophageal carcinoma considered as being secondary solid tumors after bone marrow transplantation.
BACKGROUND
Bone marrow transplantation is now an established treatment for some hematopoietic disorders and hematopoietic malignancies, and secondary solid tumors that develop after bone marrow tra... | METHOTREXATE, TACROLIMUS | DrugsGivenReaction | CC BY | 33744998 | 19,089,457 | 2021-03-20 |
What was the outcome of reaction 'Oesophageal squamous cell carcinoma'? | Three resected cases of esophageal carcinoma considered as being secondary solid tumors after bone marrow transplantation.
BACKGROUND
Bone marrow transplantation is now an established treatment for some hematopoietic disorders and hematopoietic malignancies, and secondary solid tumors that develop after bone marrow tra... | Fatal | ReactionOutcome | CC BY | 33744998 | 19,102,003 | 2021-03-20 |
What was the outcome of reaction 'Pneumonia aspiration'? | Three resected cases of esophageal carcinoma considered as being secondary solid tumors after bone marrow transplantation.
BACKGROUND
Bone marrow transplantation is now an established treatment for some hematopoietic disorders and hematopoietic malignancies, and secondary solid tumors that develop after bone marrow tra... | Recovered | ReactionOutcome | CC BY | 33744998 | 19,089,457 | 2021-03-20 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmia'. | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
What was the administration route of drug 'TOCILIZUMAB'? | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
What was the dosage of drug 'TOCILIZUMAB'? | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | 1?HOUR INFUSION OF 8 MG OF TOCILIZUMAB PER KG BODY WEIGHT (MAXIMUM DOSE 800 MG, IE, 40 ML OF CONCENT | DrugDosageText | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
What was the outcome of reaction 'Death'? | Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
BACKGROUND
Patients experiencing out-of-hospital cardiac arrest who remain com... | Fatal | ReactionOutcome | CC BY-NC-ND | 33745292 | 19,620,336 | 2021-05-11 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aphasia'. | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain oedema'. | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gaze palsy'. | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hemiplegia'. | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lethargy'. | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular stent thrombosis'. | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | ASPIRIN, ATORVASTATIN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the administration route of drug 'HEPARIN SODIUM'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the dosage of drug 'ASPIRIN'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | 100 MG | DrugDosageText | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the dosage of drug 'ATORVASTATIN'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | 20 MG | DrugDosageText | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the dosage of drug 'CLOPIDOGREL BISULFATE'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | 75 MG | DrugDosageText | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the dosage of drug 'HEPARIN SODIUM'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | 5000 IU | DrugDosageText | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the outcome of reaction 'Aphasia'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Recovered | ReactionOutcome | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the outcome of reaction 'Brain oedema'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Recovered | ReactionOutcome | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the outcome of reaction 'Drug resistance'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Recovered | ReactionOutcome | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the outcome of reaction 'Gaze palsy'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Recovered | ReactionOutcome | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the outcome of reaction 'Hemiplegia'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Recovered | ReactionOutcome | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the outcome of reaction 'Lethargy'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Recovered | ReactionOutcome | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
What was the outcome of reaction 'Vascular stent thrombosis'? | Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.
Carotid artery stenting (CAS) is an alternative strategy to carotid endarterectomy for the prevention of ischemic stroke. Acute carotid stent thrombosis (ACST) is an extremely rare but devastating complication... | Recovered | ReactionOutcome | CC BY-NC | 33745326 | 19,145,602 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated enterocolitis'. | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oesophageal ulcer'. | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | CARBOPLATIN, PEMBROLIZUMAB, PEMETREXED DISODIUM | DrugsGivenReaction | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
What is the weight of the patient? | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | 50 kg. | Weight | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
What was the administration route of drug 'CARBOPLATIN'? | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
What was the administration route of drug 'PEMETREXED DISODIUM'? | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
What was the outcome of reaction 'Immune-mediated enterocolitis'? | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | Recovered | ReactionOutcome | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
What was the outcome of reaction 'Oesophageal ulcer'? | Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esopha... | Recovered | ReactionOutcome | CC BY-NC-ND | 33746162 | 17,189,275 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure chronic'. | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | BEVACIZUMAB, CYCLOPHOSPHAMIDE, EPIRUBICIN HYDROCHLORIDE, FLUOROURACIL, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33746165 | 19,168,110 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | BEVACIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33746165 | 19,924,185 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ejection fraction decreased'. | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | BEVACIZUMAB, CYCLOPHOSPHAMIDE, EPIRUBICIN HYDROCHLORIDE, FLUOROURACIL, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33746165 | 19,168,110 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxic cardiomyopathy'. | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | BEVACIZUMAB, CYCLOPHOSPHAMIDE, EPIRUBICIN HYDROCHLORIDE, FLUOROURACIL, PACLITAXEL | DrugsGivenReaction | CC BY-NC-ND | 33746165 | 19,168,110 | 2021-09-01 |
What was the administration route of drug 'BEVACIZUMAB'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33746165 | 19,924,185 | 2021-09-01 |
What was the administration route of drug 'PACLITAXEL'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33746165 | 19,924,185 | 2021-09-01 |
What was the administration route of drug 'PIMOBENDAN'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33746165 | 19,226,267 | 2021-09-01 |
What was the dosage of drug 'CARVEDILOL'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | 2.5 MILLIGRAM DAILY; | DrugDosageText | CC BY-NC-ND | 33746165 | 19,226,267 | 2021-09-01 |
What was the dosage of drug 'ENALAPRIL'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | 2.5 MILLIGRAM DAILY; | DrugDosageText | CC BY-NC-ND | 33746165 | 19,226,267 | 2021-09-01 |
What was the dosage of drug 'EPIRUBICIN HYDROCHLORIDE'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | 75 MG/M2, CYCLIC (REPEAT EVERY 21 DAYS X8 CYCLES) | DrugDosageText | CC BY-NC-ND | 33746165 | 19,168,110 | 2021-09-01 |
What was the dosage of drug 'FUROSEMIDE'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | 20 MILLIGRAM DAILY; | DrugDosageText | CC BY-NC-ND | 33746165 | 19,226,267 | 2021-09-01 |
What was the dosage of drug 'PIMOBENDAN'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | 5 MILLIGRAM DAILY; | DrugDosageText | CC BY-NC-ND | 33746165 | 19,226,267 | 2021-09-01 |
What was the dosage of drug 'SPIRONOLACTONE'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | 50 MILLIGRAM DAILY; | DrugDosageText | CC BY-NC-ND | 33746165 | 19,226,267 | 2021-09-01 |
What was the outcome of reaction 'Cardiac failure chronic'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Recovering | ReactionOutcome | CC BY-NC-ND | 33746165 | 19,168,110 | 2021-09-01 |
What was the outcome of reaction 'Cardiac failure'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Recovering | ReactionOutcome | CC BY-NC-ND | 33746165 | 19,180,265 | 2021-09-01 |
What was the outcome of reaction 'Cardiomyopathy'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Recovering | ReactionOutcome | CC BY-NC-ND | 33746165 | 19,226,267 | 2021-09-01 |
What was the outcome of reaction 'Disease progression'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Fatal | ReactionOutcome | CC BY-NC-ND | 33746165 | 19,924,185 | 2021-09-01 |
What was the outcome of reaction 'Ejection fraction decreased'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Recovering | ReactionOutcome | CC BY-NC-ND | 33746165 | 19,168,110 | 2021-09-01 |
What was the outcome of reaction 'Toxic cardiomyopathy'? | The Effective Use of Digoxin in a Patient with Metastatic Breast Cancer and Anthracycline-induced Cardiomyopathy.
Anthracyclines have cardiotoxic side effects. Cardioprotective drugs such as angiotensin-converting enzyme inhibitors and beta-blockers are therefore recommended for patients with anthracycline-induced card... | Recovering | ReactionOutcome | CC BY-NC-ND | 33746165 | 19,168,110 | 2021-09-01 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis.
Lymphoproliferative diseases have been associated with various autoimmune diseases. We experienced a case of non-chronic lymphocytic leukemia type monoclonal B-cell lymphocytosis (MBL) that was exacerbated by increasing prednisolon... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33746170 | 20,466,809 | 2021-09-01 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis.
Lymphoproliferative diseases have been associated with various autoimmune diseases. We experienced a case of non-chronic lymphocytic leukemia type monoclonal B-cell lymphocytosis (MBL) that was exacerbated by increasing prednisolon... | 400 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY-NC-ND | 33746170 | 20,466,809 | 2021-09-01 |
What was the outcome of reaction 'Monoclonal B-cell lymphocytosis'? | Monoclonal B-cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis.
Lymphoproliferative diseases have been associated with various autoimmune diseases. We experienced a case of non-chronic lymphocytic leukemia type monoclonal B-cell lymphocytosis (MBL) that was exacerbated by increasing prednisolon... | Recovering | ReactionOutcome | CC BY-NC-ND | 33746170 | 19,221,718 | 2021-09-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lupus-like syndrome'. | Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea.
Anti-tumor necrosis factor (TNF) agents are increasingly used for rheumatic diseases and inflammatory bowel disease (IBD), but are associated with the development of anti-TNF-induced lupus (AT... | AZATHIOPRINE, INFLIXIMAB, MERCAPTOPURINE, MESALAMINE, METHOTREXATE, SULFASALAZINE | DrugsGivenReaction | CC BY-NC | 33747126 | 19,157,092 | 2021 |
What was the administration route of drug 'INFLIXIMAB'? | Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea.
Anti-tumor necrosis factor (TNF) agents are increasingly used for rheumatic diseases and inflammatory bowel disease (IBD), but are associated with the development of anti-TNF-induced lupus (AT... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33747126 | 19,157,092 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | BENDAMUSTINE, BLEOMYCIN SULFATE, BORTEZOMIB, BRENTUXIMAB VEDOTIN, CARMUSTINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DACARBAZINE, DOXORUBICIN, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, MYCOPHENOLATE MOFETIL, PREDNISONE, PROCARBAZINE, THIOTEPA, VINBLASTINE, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Graft versus host disease'. | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | BENDAMUSTINE, BLEOMYCIN SULFATE, BORTEZOMIB, BRENTUXIMAB VEDOTIN, CARMUSTINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DACARBAZINE, DOXORUBICIN, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, MYCOPHENOLATE MOFETIL, PREDNISONE, PROCARBAZINE, THIOTEPA, VINBLASTINE, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | BENDAMUSTINE, BLEOMYCIN SULFATE, BORTEZOMIB, BRENTUXIMAB VEDOTIN, CARMUSTINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DACARBAZINE, DOXORUBICIN, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, MYCOPHENOLATE MOFETIL, PREDNISONE, PROCARBAZINE, THIOTEPA, VINBLASTINE, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | BENDAMUSTINE, BLEOMYCIN SULFATE, BORTEZOMIB, BRENTUXIMAB VEDOTIN, CARMUSTINE, CYCLOPHOSPHAMIDE, CYCLOSPORINE, CYTARABINE, DACARBAZINE, DOXORUBICIN, ETOPOSIDE, FLUDARABINE PHOSPHATE, MELPHALAN, MYCOPHENOLATE MOFETIL, PREDNISONE, PROCARBAZINE, THIOTEPA, VINBLASTINE, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'BLEOMYCIN SULFATE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'DACARBAZINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'DOXORUBICIN'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'PREDNISONE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Oral | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'PROCARBAZINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Oral | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'VINBLASTINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the administration route of drug 'VINCRISTINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'BENDAMUSTINE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 90 MILLIGRAM/SQ. METER, FOR 2 DAYS | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'BLEOMYCIN SULFATE'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 10 MILLIGRAM/SQ. METER, DAYS 1 AND 15 | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
What was the dosage of drug 'BRENTUXIMAB VEDOTIN'? | Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach.
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate... | 1.8 MILLIGRAM/SQ. METER, 1 DAY | DrugDosageText | CC BY-NC | 33747411 | 19,161,436 | 2021-03-05 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.